KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Invested Capital (2025)

Historic Return on Invested Capital for Rigel Pharmaceuticals (RIGL) over the last 5 years, with Q3 2025 value amounting to 0.94%.

  • Rigel Pharmaceuticals' Return on Invested Capital changed N/A to 0.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.94%, marking a year-over-year change of. This contributed to the annual value of 4.24% for FY2024, which is N/A changed from last year.
  • Rigel Pharmaceuticals' Return on Invested Capital amounted to 0.94% in Q3 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Return on Invested Capital ranged from a high of 6.72% in Q3 2022 and a low of 51.4% during Q2 2022
  • Its 4-year average for Return on Invested Capital is 5.14%, with a median of 0.17% in 2021.
  • The largest annual percentage gain for Rigel Pharmaceuticals' Return on Invested Capital in the last 5 years was 68900bps (2022), contrasted with its biggest fall of -513400bps (2022).
  • Over the past 4 years, Rigel Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.32% in 2021, then surged by 2183bps to 6.72% in 2022, then tumbled by -268bps to 11.29% in 2024, then soared by 108bps to 0.94% in 2025.
  • Its Return on Invested Capital stands at 0.94% for Q3 2025, versus 1.5% for Q2 2025 and 1.95% for Q1 2025.